Internal Deadline (Application): Pfizer - Raising Awareness and Promoting Timely Diagnosis of TTR Amyloidosis
Global Bridges at Mayo Clinic and Pfizer Global Medical Grants have supported independent projects focused on raising awareness and closing knowledge gaps to reduce the time it takes for patients to be correctly diagnosed and make treatment more accessible while supporting the development of a global network of TTR amyloidosis experts.
Pfizer is interested in receiving proposals that:
- Reduce the time to correct diagnosis, among a broad audience of health care professionals, including increasing coordination across specialties.
- Build on evidence and international best practices.
- Include a robust and well-defined plan for evaluation and dissemination.
- Support the development of a global network of healthcare professionals capable of diagnosing and treating TTR amyloidosis,
- Support the development of a global network of TTR amyloidosis experts
- Include a plan to sustain the project beyond the period of funding.
Individual projects requesting up to $225,000 will be considered. Pfizer anticipates funding 3 projects.
Full details about this call are available here.
Internal deadline: April 18, 2024 at 4:30pm. Contact email is ird@dal.ca
Funder deadline: May 2, 2024. Katie Kemper at Global Bridges (kemper.katherine@mayo.edu) or the Pfizer Grant Officer, Amanda Stein (amanda.j.stein@pfizer.com)
Time